Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Innate Pharma (IPHA) Interest Coverage Ratio (2019 - 2025)

Historic Interest Coverage Ratio for Innate Pharma (IPHA) over the last 7 years, with Q2 2025 value amounting to 9.07.

  • Innate Pharma's Interest Coverage Ratio fell 2884.4% to 9.07 in Q2 2025 from the same period last year, while for Jun 2025 it was 10.17, marking a year-over-year decrease of 4438.22%. This contributed to the annual value of 12.97 for FY2024, which is 8792.99% down from last year.
  • Latest data reveals that Innate Pharma reported Interest Coverage Ratio of 9.07 as of Q2 2025, which was down 2884.4% from 12.45 recorded in Q4 2024.
  • Over the past 5 years, Innate Pharma's Interest Coverage Ratio peaked at 10894.94 during Q4 2022, and registered a low of 0.41 during Q2 2023.
  • Over the past 5 years, Innate Pharma's median Interest Coverage Ratio value was 11.38 (recorded in 2021), while the average stood at 1563.59.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first skyrocketed by 9565419.63% in 2022, then plummeted by 9996.21% in 2023.
  • Innate Pharma's Interest Coverage Ratio (Quarter) stood at 11.38 in 2021, then surged by 95654.2% to 10894.94 in 2022, then crashed by 99.96% to 4.13 in 2023, then surged by 201.69% to 12.45 in 2024, then decreased by 27.11% to 9.07 in 2025.
  • Its Interest Coverage Ratio stands at 9.07 for Q2 2025, versus 12.45 for Q4 2024 and 12.75 for Q2 2024.